Cronus Pharma Launched Florfinasone Otic for Dogs
The new FDA-approved treatment offers a multi-action approach to managing canine otitis externa.
Updated on Oct. 1, 2026 in Veterinary Medicine
Live Poll
Do you trust new pharmaceutical treatments for your pets?
Cronus Pharma has launched Florfinasone Otic, a new medication designed to treat canine otitis externa. The product received FDA approval under ANADA #200-848 and specifically targets common bacterial and fungal infections in dogs.
Why it matters
Otitis externa remains a frequent concern for dog owners, and this new treatment combines antibiotic, antifungal, and anti-inflammatory properties to address multiple facets of the condition at once.
The medication contains 16.6 mg/mL of florfenicol, 14.8 mg/mL of terbinafine, and 2.2 mg/mL of mometasone furoate. It is administered via 1mL single-use dropperettes and is sold in cartons of ten.
The players
Cronus Pharma
An East Brunswick, New Jersey-based pharmaceutical company that develops and manufactures products for veterinary health.
Food and Drug Administration
The federal agency responsible for regulating animal drugs and ensuring the safety and efficacy of veterinary medications.
The details
Florfinasone Otic works by inhibiting both protein and ergosterol synthesis while providing targeted anti-inflammatory relief to the ear. The medication is formulated exclusively for canine use and is not indicated for cats.
Timeline
October 1, 2026: Cronus Pharma announced the product launch.
Culture Shift
The introduction of this multi-action treatment reflects a broader industry movement toward simplified, all-in-one care for common veterinary ailments. This approach positions the product to compete in the growing market for targeted, home-administered pet medications.
Dog owners should consult their veterinarian to determine if this new medication is appropriate for their pet's specific ear infection. The transition to single-use dropperettes may simplify the treatment process by ensuring accurate dosing during the course of the medication.
The takeaway
This new treatment offers pet owners a consolidated way to manage ear health with a single, pre-measured dose. Owners should strictly avoid using this product on cats, as it is formulated specifically for the anatomy and needs of dogs.
Further reading
For more information on the current landscape of pet health treatments, visit the Veterinary Medicine section.
More information
For additional product details and company information, visit the Cronus Pharma official website.
Live Poll
Do you trust new pharmaceutical treatments for your pets?
